|

Sitagliptin Clinical Trials

6 actively recruiting trials across 3 locations

▲ +2 trials since July 2026

Also known as: Januvia, Sitagliptin phosphate, brand name:Jie Nuo Wei

Pipeline

Phase 1: 1Phase 2: 2Phase 3: 1Phase 4: 1

Top Sponsors

  • The University of Texas Health Science Center at San Antonio1
  • Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University1
  • Peking University Third Hospital1
  • Kailin Yang, MD, PhD1
  • Fudan University1

Indications

  • Cancer4
  • Diabetes2
  • Glioblastoma2
  • Grade 4 Malignant Glioma of Brain (Disorder)1
  • Type 2 Diabetes (Adult Onset)1

Other3 trials

Efficacy and Safety of Canagliflozin in the Treatment of Type 2 Diabetes With Mild Cognitive Impairment
Phase 4
Sitagliptin or BeiDouGen Capsule Improve the Pregnancy Outcome in Patients with PCOS
N/A
Sun Yat-Sen Treatment Strategy for Enhancing Response in Muscle-invasive Bladder Cancer
Phase 2

Iowa City, Iowa1 trial

Sitagliptin in Recurrent/Progressive Grade 4 Glioma

University of Iowa Health Care

Phase 1

Cleveland, Ohio1 trial

A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas

Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute

Phase 2

San Antonio, Texas1 trial

Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes

University Health System Texas Diabetic Institute

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.